Pregnancy outcomes in women with type 1 diabetes using insulin degludec

Pregnancy outcomes in women with type 1 diabetes using insulin degludec: response to Kamran et al

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › fagfællebedømt

Præsentation
Citationsformater

Lene Ringholm
Nicoline Callesen Do
Damm, Peter
Mathiesen, Elisabeth

Originalsprog	Engelsk
Tidsskrift	Acta Diabetologica
Vol/bind	60
Udgave nummer	1
Sider (fra-til)	141-142
Antal sider	2
ISSN	0940-5429
DOI	https://doi.org/10.1007/s00592-022-01996-8
Status	Udgivet - 2023

Bibliografisk note

Funding Information:
ERM has received fees for giving talks for Novo Nordisk A/S. ERM, PD and LR are participating in multicenter and multinational clinical studies on the use of insulin in pregnant women with pre-existing diabetes in collaboration with Novo Nordisk; no personal honorarium is involved. NCD is funded by Novo Nordisk Foundation.

Funding Information:
L. Ringholm has received a research grant from Novo Nordisk (Grant number: U1111-1209-6358) for an investigator-sponsored study.

ID: 334305580